Surgery for seminoma that has spread to lymph nodes
Part of Cancer, Hormones & metabolism, Kidney & urinary clinical trials.
This trial tests if removing the involved lymph nodes in the abdomen (retroperitoneal lymph node dissection) is a good treatment for seminoma that has spread to a small number of lymph nodes. It may help patients avoid more chemotherapy or radiation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have pure seminoma confirmed after your testicle removal surgery.
- You either had stage 1 cancer that later spread to lymph nodes while being watched, or you were first diagnosed with stage 2 cancer with lymph node involvement.
- You have no more than 2 enlarged lymph nodes in your abdomen, each no larger than 3 cm, as seen on a scan within the past 2 months.
- Your blood tumor markers (AFP, HCG, LDH) are all normal within 2 weeks before surgery.
- Your surgeon agrees that having this surgery is safe for you, and you do not have any condition that makes the surgery too risky.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two standard treatments—surgery to remove lymph nodes in the abdomen (RPLND) versus chemotherapy—for men with testicular cancer that has spread to a small area in the abdomen. The goal is to see which approach works better and has fewer side effects.
This study reviews 20 years of experience in removing lymph nodes in the abdomen (RPLND) for testicular cancer. It aims to understand the outcomes of this surgery for people who had it after chemotherapy or for early-stage cancer.
This trial tests a newer, less invasive surgery using a dye called indocyanine green to find and remove lymph nodes in the back of the abdomen for early-stage testicular cancer. It compares this approach to the current standard procedure to see if it works just as well with fewer side effects.
This trial studies whether a robotic operation (removing cancerous lymph nodes in the back of the belly) is a good first treatment for certain early-stage testicular seminoma cases. It aims to cure cancer while avoiding or delaying other treatments, and uses follow-up plans to check results.
This trial is testing whether removing affected lymph nodes with surgery (RPLND) works well alone for seminoma testicular cancer that has spread to nearby nodes but is still relatively small. It is for patients who have not had extensive chemo or radiation.
This trial tests lowering the intensity of treatment (de-escalation) for Stage II seminoma, a type of testicular cancer. You may receive either a surgery to remove lymph nodes or a single round of chemotherapy (carboplatin), instead of more aggressive standard treatments, to see if it's safe and effective.
Hear when a new Testicular Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.